Phentermine Hydrochloride
- Product NDC
- 50436-6744
- 11-digit product format
- 504366744
- Labeler code
- 50436
- Product ID
- 50436-6744_60ddd1bf-6ff5-442c-9fe8-417ebff5265a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Phentermine Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Unit Dose Services
- Application
- ANDA040555
- Marketing category
- ANDA
- Marketing start
- 2005-04-15
- Marketing end
- 0000-00-00
- Substance
- PHENTERMINE HYDROCHLORIDE
- Active strength
- 38 mg/1
- Pharmacologic classes
- Appetite Suppression [PE],Increased Sympathetic Activity [PE],Sympathomimetic Amine Anorectic [EPC]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 50436-6744-1 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-3635-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use phentermine hydrochloride tablets, USP safely and effectively. See full prescribing information for phentermine hydrochloride tablets, USP . PHENTERMINE Hydrochloride Tablets, USP for oral use CIV Initial U.S. Approval: 1959 |
| 50436-6744-2 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-3635-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use phentermine hydrochloride tablets, USP safely and effectively. See full prescribing information for phentermine hydrochloride tablets, USP . PHENTERMINE Hydrochloride Tablets, USP for oral use CIV Initial U.S. Approval: 1959 |
| 50436-6744-3 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-3635-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use phentermine hydrochloride tablets, USP safely and effectively. See full prescribing information for phentermine hydrochloride tablets, USP . PHENTERMINE Hydrochloride Tablets, USP for oral use CIV Initial U.S. Approval: 1959 |
| 50436-6744-4 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-3635-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use phentermine hydrochloride tablets, USP safely and effectively. See full prescribing information for phentermine hydrochloride tablets, USP . PHENTERMINE Hydrochloride Tablets, USP for oral use CIV Initial U.S. Approval: 1959 |
| 50436-6744-1 | 2021-08-06 | C162847 | 48780-1 | ba0f9c33-3635-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use phentermine hydrochloride tablets, USP safely and effectively. See full prescribing information for phentermine hydrochloride tablets, USP . PHENTERMINE Hydrochloride Tablets, USP for oral use CIV Initial U.S. Approval: 1959 |
| 50436-6744-2 | 2021-08-06 | C162847 | 48780-1 | ba0f9c33-3635-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use phentermine hydrochloride tablets, USP safely and effectively. See full prescribing information for phentermine hydrochloride tablets, USP . PHENTERMINE Hydrochloride Tablets, USP for oral use CIV Initial U.S. Approval: 1959 |
| 50436-6744-3 | 2021-08-06 | C162847 | 48780-1 | ba0f9c33-3635-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use phentermine hydrochloride tablets, USP safely and effectively. See full prescribing information for phentermine hydrochloride tablets, USP . PHENTERMINE Hydrochloride Tablets, USP for oral use CIV Initial U.S. Approval: 1959 |
| 50436-6744-4 | 2021-08-06 | C162847 | 48780-1 | ba0f9c33-3635-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use phentermine hydrochloride tablets, USP safely and effectively. See full prescribing information for phentermine hydrochloride tablets, USP . PHENTERMINE Hydrochloride Tablets, USP for oral use CIV Initial U.S. Approval: 1959 |
| 50436-6744-1 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-3635-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use phentermine hydrochloride tablets, USP safely and effectively. See full prescribing information for phentermine hydrochloride tablets, USP . PHENTERMINE Hydrochloride Tablets, USP for oral use CIV Initial U.S. Approval: 1959 |
| 50436-6744-2 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-3635-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use phentermine hydrochloride tablets, USP safely and effectively. See full prescribing information for phentermine hydrochloride tablets, USP . PHENTERMINE Hydrochloride Tablets, USP for oral use CIV Initial U.S. Approval: 1959 |
| 50436-6744-3 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-3635-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use phentermine hydrochloride tablets, USP safely and effectively. See full prescribing information for phentermine hydrochloride tablets, USP . PHENTERMINE Hydrochloride Tablets, USP for oral use CIV Initial U.S. Approval: 1959 |
| 50436-6744-4 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-3635-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use phentermine hydrochloride tablets, USP safely and effectively. See full prescribing information for phentermine hydrochloride tablets, USP . PHENTERMINE Hydrochloride Tablets, USP for oral use CIV Initial U.S. Approval: 1959 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50436-6744-1 | Phentermine Hydrochloride | 14 in 1 BOTTLE | TABLET | 14 | | 10 |
| 50436-6744-2 | Phentermine Hydrochloride | 7 in 1 BOTTLE | TABLET | 7 | | 10 |
| 50436-6744-3 | Phentermine Hydrochloride | 30 in 1 BOTTLE | TABLET | 30 | | 10 |
| 50436-6744-4 | Phentermine Hydrochloride | 28 in 1 BOTTLE | TABLET | 28 | | 10 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50436-6744 | PHENTERMINE HYDROCHLORIDE TABLET [UNIT DOSE SERVICES] | 10 | Legacy NDC, 4 package rows | 20210808_ef061dd2-1b35-49bf-beda-8c9fe02e5f9f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50436-6744-1 | 50436674401 | 14 TABLET in 1 BOTTLE (50436-6744-1) | 14 tablet | 2021-08-05 | 0000-00-00 | No | No | Current |
| 50436-6744-2 | 50436674402 | 7 TABLET in 1 BOTTLE (50436-6744-2) | 7 tablet | 2021-08-05 | 0000-00-00 | No | No | Current |
| 50436-6744-3 | 50436674403 | 30 TABLET in 1 BOTTLE (50436-6744-3) | 30 tablet | 2021-08-05 | 0000-00-00 | No | No | Current |
| 50436-6744-4 | 50436674404 | 28 TABLET in 1 BOTTLE (50436-6744-4) | 28 tablet | 2021-08-05 | 0000-00-00 | No | No | Current |